Sleeve Gastrectomy Suppresses Hepatic De Novo Cholesterogenesis and Improves Hepatic Cholesterol Accumulation in Obese Rats with Type 2 Diabetes Mellitus

Nutrition ◽  
2021 ◽  
pp. 111531
Author(s):  
Fu Chen ◽  
Bingyang Liu
2013 ◽  
Vol 15 (12) ◽  
pp. 990-995 ◽  
Author(s):  
Arundhati Dasgupta ◽  
Jasjeet Wasir ◽  
Maria Beloyartseva ◽  
Sandeep Malhotra ◽  
Ambrish Mithal

Aging ◽  
2020 ◽  
Vol 12 (17) ◽  
pp. 17480-17502
Author(s):  
Lijing Zhang ◽  
Wen Zhou ◽  
Libin Zhan ◽  
Shenglin Hou ◽  
Chunyan Zhao ◽  
...  

2019 ◽  
Vol 29 (9) ◽  
pp. 2957-2962 ◽  
Author(s):  
Michał Wysocki ◽  
Maciej Walędziak ◽  
Hady Razak Hady ◽  
Mikołaj Czerniawski ◽  
Monika Proczko-Stepaniak ◽  
...  

Metabolites ◽  
2020 ◽  
Vol 10 (8) ◽  
pp. 308
Author(s):  
Ariana Picu ◽  
Laura Petcu ◽  
Diana Simona Ştefan ◽  
Grațiela Grădișteanu Pîrcălăbioru ◽  
Manuela Mitu ◽  
...  

Geography is one of the key drivers of the significant variation in the etiopathogenic profile and prevalence of type 2 diabetes mellitus (T2DM) and obesity, therefore geographically based data are fundamental for implementing the appropriate interventions. Presently, the selection criteria of T2DM and obesity patients for laparoscopic sleeve gastrectomy (LSG) have not reached a worldwide consensus—highlighting the need for sharing experts’ guidance in the preoperative evaluation, choice of the interventional procedure, perioperative management and patient long-term care. The aim of the current study was to evaluate the impact of LSG on T2DM (T2DM) remission in Romanian obese male patients, based on a multiparametric, prospective investigation. We have conducted a randomized controlled study on 41 obese male participants with the body mass index (BMI) ≥ 30 kg/m2, aged 30–65 years, which were randomly divided in two study groups: one receiving conventional treatment and the second undergoing LSG. The clinical and anthropometrical parameters, resting metabolic rate, general biochemical status, adipocytes profile, gastrointestinal hormones levels, proinflammatory, oxidant and antioxidant profiles were determined at three time points: V1 (baseline), V2 (after six months) and V3 (after 12 months). Glycated hemoglobin (HbA1c), blood glucose levels, BMI, weight, visceral fat level, HDL-cholesterol, incretin hormones, proinflammatory and the oxidative stress status were significantly improved in the LSG versus conventional treatment group. This is the first study reporting on the evaluation of metabolic surgery impact on Romanian obese male patients with T2DM. Our results confirm that LSG could contribute to T2DM remission in patients with diabesity, but this beneficial effect seems to be critically influenced by the duration of T2DM rather than by the obesity status. Our results show that, in addition to the parameters included in the prediction algorithm, the proinsulin levels, proinsulin/insulin ratio and the visceral fat percentage could bring added value to the assessment of metabolic status.


Sign in / Sign up

Export Citation Format

Share Document